Brief: Carl Gordon Reports 9.99% Stake In Chemomab Therapeutics As Of Sept 12 Versus 16.0% As Reported In March 11 - SEC Filing
Sept 16 (Reuters) - Chemomab Therapeutics Ltd CMMB.O :
* CARL L. GORDON REPORTS 9.99% STAKE IN CHEMOMAB
THERAPEUTICS AS
OF SEPT 12 VERSUS 16.0% AS REPORTED IN MARCH 11 - SEC FILING
Source text for Eikon: ID:n0000947871-24-000757
Further company coverage: CMMB.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Chemomab Therapeutics
See all newsBrief: Chemomab Therapeutics Announces Second Quarter 2026 Financial Results And Provides Corporate Update
Chemomab Therapeutics Ltd expected to post a loss of 15 cents a share - Earnings Preview
Israel's Chemomab Q4 net loss narrows on lower R&D spend
Brief: Chemomab Therapeutics Announces Nebokitug Phase 2 Spring Trial Results
Brief: Chemomab Therapeutics Announces Third Quarter 2025 Financial Results And Provides Corporate Update